We recommend glutathione IV therapy sessions to anyone who's looking to prevent disease, so don't confuse glutathione drips with something only for the sick
Giralt M, Gavalda-Navarro A, Villarroya F
Preliminary data show that antibodies from SARS-CoV-2-nave donors who had high reactivity to seasonal human coronavirus strains were found to have low levels of cross-reactivity against the nucleocapsid and S2 subunit of SARS-CoV-2 (ref
Clinical trials tested doses ranging from 250mcg to 1mg daily, with most protocols settling around 300-500mcg for optimal fat metabolism support
In Europe, recent shortages of Type IV patch test allergens further contribute to lack of testing availability in some settings, potentially prolonging time to diagnosis and symptom control for those with suspected ACD [42, 43, 45,46,47]